Mark Bagarazzi - Net Worth and Insider Trading

Mark Bagarazzi Net Worth

The estimated net worth of Mark Bagarazzi is at least $8,350 dollars as of 2024-09-20. Mark Bagarazzi is the Chief Medical Officer of Inovio Pharmaceuticals Inc and owns about 1,250 shares of Inovio Pharmaceuticals Inc (INO) stock worth over $8,350. Details can be seen in Mark Bagarazzi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Bagarazzi has not made any transactions after 2013-04-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Mark Bagarazzi

To

Mark Bagarazzi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Bagarazzi owns 1 companies in total, including Inovio Pharmaceuticals Inc (INO) .

Click here to see the complete history of Mark Bagarazzi’s form 4 insider trades.

Insider Ownership Summary of Mark Bagarazzi

Ticker Comapny Transaction Date Type of Owner
INO Inovio Pharmaceuticals Inc 2016-03-05 Chief Medical Officer

Mark Bagarazzi Latest Holdings Summary

Mark Bagarazzi currently owns a total of 1 stock. Mark Bagarazzi owns 1,250 shares of Inovio Pharmaceuticals Inc (INO) as of April 16, 2013, with a value of $8,350.

Latest Holdings of Mark Bagarazzi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INO Inovio Pharmaceuticals Inc 2013-04-16 1,250 6.68 8,350

Holding Weightings of Mark Bagarazzi


Mark Bagarazzi Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Bagarazzi has made a total of 0 transactions in Inovio Pharmaceuticals Inc (INO) over the past 5 years. The most-recent trade in Inovio Pharmaceuticals Inc is the acquisition of 1,250 shares on April 16, 2013, which cost Mark Bagarazzi around $33,600.

Insider Trading History of Mark Bagarazzi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Bagarazzi Trading Performance

GuruFocus tracks the stock performance after each of Mark Bagarazzi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Bagarazzi is 127.94%. GuruFocus also compares Mark Bagarazzi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Bagarazzi within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mark Bagarazzi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mark Bagarazzi

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 22.06 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 17.24 LIMIT LIMIT LIMIT LIMIT LIMIT

Mark Bagarazzi Ownership Network

Ownership Network List of Mark Bagarazzi

No Data

Ownership Network Relation of Mark Bagarazzi

Insider Network Chart

Mark Bagarazzi Owned Company Details

What does Inovio Pharmaceuticals Inc do?

Who are the key executives at Inovio Pharmaceuticals Inc?

Mark Bagarazzi is the Chief Medical Officer of Inovio Pharmaceuticals Inc. Other key executives at Inovio Pharmaceuticals Inc include Chief Medical Officer Michael John Sumner , Chief Scientific Officer Laurent Humeau , and CFO Peter Kies .

Inovio Pharmaceuticals Inc (INO) Insider Trades Summary

Over the past 18 months, Mark Bagarazzi made no insider transaction in Inovio Pharmaceuticals Inc (INO). Other recent insider transactions involving Inovio Pharmaceuticals Inc (INO) include a net sale of 5,700 shares made by Lota S. Zoth ,

In summary, during the past 3 months, insiders sold 0 shares of Inovio Pharmaceuticals Inc (INO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 475 shares of Inovio Pharmaceuticals Inc (INO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 475 shares.

Inovio Pharmaceuticals Inc (INO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inovio Pharmaceuticals Inc Insider Transactions

No Available Data

Mark Bagarazzi Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Bagarazzi. You might contact Mark Bagarazzi via mailing address: 660 W. Germantown Pike, Suite 110, Plymouth Meeting Pa 19462.

Discussions on Mark Bagarazzi

No discussions yet.